Skip to main content

Coronvirus: Drugs

Question for Department of Health and Social Care

UIN 99393, tabled on 7 January 2022

To ask the Secretary of State for Health and Social Care, in what way (a) clinicians, (b) patient groups, (c) hon. Members and (d) others can make representations to the relevant NHS unit about including additional individual patients or groups of patients who might be considered to be eligible to receive covid-19 antiviral treatments, who are currently not considered eligible.

This answer is the replacement for a previous holding answer.

Answered on

17 January 2022

The cohorts eligible for treatment with antivirals and monoclonal antibodies have been determined by an independent expert group commissioned by the Department and included in a clinical policy agreed by the United Kingdom Chief Medical Officers. This was created based on evidence that certain health conditions can make a patient much more likely to progress to severe disease. As a result, these patients could benefit the most from novel medications.

We are currently reviewing a process for considering changes to this cohort and an update will be available shortly. In the meantime, if a patient believes they may be eligible to access these treatments, they are advised to contact their general practitioner or consultant or NHS 111.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.